149
Views
5
CrossRef citations to date
0
Altmetric
Oncology

Multidrug resistance in mucoepidermoid carcinoma of the parotid gland – immunohistochemical investigations of P-glycoprotein expression

, , , , &
Pages 552-557 | Received 28 Sep 2012, Accepted 06 Nov 2012, Published online: 28 Jan 2013

References

  • Spiro RH, Huvos AG, Strong EW. Cancer of the parotid gland: a clinicopathological study of 288 primary cases. Am J Surg 1975;130:452–9.
  • Goode RK, El-Naggar AK. World Health Organization classification of tumours. 2005. In Barnet L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumours: mucoepidermoid carcinoma. Albany, NY: WHO Publication Center. p 219–22.
  • Sobin LH, Gospodarowicsz MK, Wittekind CH. 2009. UICC International Union Against Cancer. TNM classification of malignant tumours. 7th edition. New York: John Wiley & Sons Ltd. p 54–7.
  • Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577–80.
  • Flynn SD, Murren JR, Kirby WM, Honig J, Kan L, Kinder BK. P-glycoprotein expression and multidrug resistance in adrenocortical carcinoma. Surgery 1992;112:981–6.
  • Grogan T, Dalton W, Rybski J, Spier C, Meltzer P, Richter L, et al. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. Lab Invest 1990;63:815–24.
  • Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, et al. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988;48:1926–9.
  • Scheper RJ, Bulte JWM, Brakkee JGP, Quak JJ, van der Schoot E, Balm AJM, et al. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug resistance. Int J Cancer 1988;42:389–94.
  • Fairchild CR, Cowan KH. Keynote address: multidrug resistance: a pleiotropic response to cytotoxic drugs. Int J Radiat Oncol Biol Phys 1991;20:361–7.
  • Pastan I, Gottesman M. Multiple-drug resistance in human cancer. N Engl J Med 1987;316:1388–92.
  • Seifert G, Miehlke A, Haubrich J, Chilla R. 1984. Salivary tumors of epithelial origin. In Diseases of the salivary glands: pathology-diagnosis-treatment-facial nerve surgery. New York: George Thieme Verlag. p 231–8.
  • Ford JM, Hait WN. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990;42:155–99.
  • Beck WT. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. J Natl Cancer Inst 1989;81:1683–5.
  • Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84:7735–8.
  • Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265–9.
  • Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:116–24.
  • Chan HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusek N, et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991;325:1608–14.
  • Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J Clin Oncol 1991;9:17–24.
  • Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001;25:835–45.
  • Li DW, Goa S, Shen B, Dong P. Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma. Med Oncol 2011;28:S333–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.